Executive Summary Available: Human Abuse Liability & Abuse-Deterrent Formulations Summit

Dear Colleague,

We invite you to download the executive summary of last year's 3rd Human Abuse Liability & Abuse-Deterrent Formulations Summit, which took place November 2–3, 2016 in Arlington, VA. Read it to get highlights on: 

• FDA's Doug Throckmorton discussing the ongoing scientific and policy framework behind their draft guidelines
• Procedures for securing improved label claims
• Selections of ideal endpoints in clinical studies
• Strategies for preparing for advisory committee meetings

...and much more!

Click here to download the summary. 

The 4th Human Abuse Liability & Abuse-Deterrent Formulations (November 6–7) is the largest and most specificall -focused event devoted to the technical, regulatory, and marketplace strategies needed to improve the outlook for your opioids. Now in its fourth year, this conference offers unequaled learning and networking opportunities as you face unprecedented scrutiny from regulators, prescribers, and the general public.

Register online or by calling 866-207-6528 today. Make sure to mention Priority Code C899EM7.

I hope to see you there!

Sincerely,

Matt Greenbaum
Production Team Leader
ExL Events, a division of Questex, LLC